Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: drug policy
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy
This article is the third part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Top News
-
A veiled bet: The West Coast Pipeline and the case Canadians haven’t been shown
-
Gruesome beheading attempt in Belfast a warning against fast-track asylum processes: Michael Barutciski in the National Post
-
Canada’s conversation about new submarines is failing to ask the most important question: Rob Huebert in The Globe and Mail
-
Cutting off oil exports to spite Trump would cripple Canada: Heather Exner-Pirot in the National Post
-
Degrees of decline – Credential creep, lost trust, and the reckoning facing Canada’s universities: David Polansky for Inside Policy
